Related Experiment Video
Updated: Aug 15, 2026

Isolation and Identification of Waterborne Antibiotic-Resistant Bacteria and Molecular Characterization of their Antibiotic Resistance Genes
Published on: March 3, 2023
Occurrence of antibiotic resistant enterococci in clinical specimens from a pediatric hospital
Maria Rudy1, Maria Zientara, Tomasz Bek
1Department of Medical Microbiology, Medical University of Silesia, Katowice, Poland.
Abstract:
Enterococcal infection has become a major clinical problem and E. faecalis and E. faecium are the most frequently isolated species. However, the isolation of other species (E. casseliflavus, E. gallinarum, E. durans) from clinical materials was reported recently. The aim of this study was to evaluate drug resistance of 97 species of enterococci isolated from clinical specimens of Upper Silesian Health Center of Child and Mother in Katowice. Each strain was tested for susceptibility to vancomycin, teicoplanin, aminoglycosides (gentamycin and streptomycin) and synercid (quinupristine/ dalfopristine) by the E-test method. Fifty three percent of studied enterococci demonstrated high level aminoglycoside resistance (HLAR) (MIC > 1024 microg/ml). Sixty three strains of E. faecalis were sensitive to vancomycin (MIC 1-4 microg/ml), but 5 strains demonstrated low sensitivity (3 strains with MIC = 6 microg/ml and 2 strains with MIC = 24 microg/ml). All studied enterococci were sensitive to teicoplanin (MIC < 2 microg/ml). A high percentage of E. faecium (70%) resistant to synercid was demonstrated (MIC = 2-24 microg/ml). Infection control and monitoring of antibiotic sensitivity among isolated hospital strains may prevent the transmission of resistant strains in a pediatric hospital.
Insights
Enterococcal infections are a growing concern. This study found high rates of antibiotic resistance, particularly high-level aminoglycoside resistance (HLAR) and synercid resistance in E. faecium, highlighting the need for infection control.
Area of Science:
- Microbiology
- Infectious Diseases
- Clinical Pharmacy
Background:
- Enterococcal infections pose significant clinical challenges, with Enterococcus faecalis and Enterococcus faecium being the most common culprits.
- Recent reports indicate the isolation of other enterococcal species from clinical settings, expanding the spectrum of concern.
Purpose of the Study:
- To assess the drug resistance patterns of 97 enterococcal strains isolated from clinical specimens.
- To evaluate susceptibility to vancomycin, teicoplanin, aminoglycosides, and synercid in a pediatric hospital setting.
Main Methods:
- Utilized the E-test method for susceptibility testing.
- Tested 97 enterococcal isolates against vancomycin, teicoplanin, gentamycin, streptomycin, and quinupristine/dalfopristine.
Main Results:
- 53% of isolates exhibited high-level aminoglycoside resistance (HLAR).
- All strains were susceptible to teicoplanin.
- 70% of Enterococcus faecium strains showed resistance to synercid.
- Most Enterococcus faecalis strains were sensitive to vancomycin, with a few showing low sensitivity.
Conclusions:
- Antibiotic resistance, including HLAR and synercid resistance, is prevalent in clinical enterococcal isolates.
- Teicoplanin demonstrated broad susceptibility across tested enterococci.
- Effective infection control and antibiotic sensitivity monitoring are crucial to prevent the spread of resistant strains in pediatric healthcare settings.
Related Concept Videos
Clinical Significance of Antibiotic Resistance
Mechanism of Antibiotic Resistance in MRSA
Development of Antibiotic Resistance
Bacterial Gastroenteritis
Urine Studies II: Urine Culture and Sensitivity Test
Antibiotic Selection
